Welcome

Steno Diabetes Center is a world leading institution within diabetes care and prevention. Steno is owned by Novo Nordisk A/S and is a not for profit organisation working in partnership with the Danish healthcare system. Steno treats around 6200 people with diabetes. Read more

News

2 May 2012
Two new professors at Steno
April 1st, two well-known researchers Peter Rossing and Lise Tarnow have been awarded a five-year research professorship at the University of Aarhus.
Read more

10 February 2012
Steno awarded two EU research grants
The EU Seventh Framework Programme (FP7) has awarded Steno Diabetes Center with research grants totalling 11 million Euros.
The grants will fund two prevention projects, DEXLIFE and PRIORITY, to run over the next 3-5 years involving a wide range of European partners, including diabetes clinics, universities and industry. Read more 
Press release  1 March

Steno Rounds

May 24
Jens Juul Holst, Scientific Director at The Novo Nordisk Foundation Center for Basic Metabolic Research: Incretins, GLP-1 and diabetes –  new insights.
Read invitation
See previous lectures 

Steno Symposium

New book

In balance with chronic illness
Tools for Patient Education
By Gitte Engelund, Steno Health Promotion Center
Read more 


Download
Steno Activity report 2011
Scientific publications 2011